Showing results (71-80 of 764) with videos related to

Sort By:
Pageof 77
Blood|October 3, 2015
Is the open mouth mightier than the needle?Peter Martin
Hematology. American Society of Hematology. Education Program|December 10, 2017
Optimizing therapy for mantle cell lymphomaPeter Martin
Blood|January 30, 2019
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphomaPeter Martin, Nancy L Bartlett, Kristie A Blum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphomaJia Ruan, Peter Martin, Richard R Furman, et al.
Seminars in Oncology|August 27, 2003
CD22-directed monoclonal antibody therapy for lymphomaAbby B Siegel, David M Goldenberg, Alessandra Cesano, et al.
AIDS Patient Care and Stds|February 23, 2008
Improving outcomes for patients with Burkitt lymphoma and HIVVictoria S Blinder, Amy Chadburn, Richard R Furman, et al.
American Journal of Clinical Oncology|May 3, 2024
Racial Disparities in Endometrial Cancer Clinical Trial Representation: Exploring the Role of Eligibility CriteriaJennifer L Wolf, Alexandra Hamilton, Anjile An, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Outcome of deferred initial therapy in mantle-cell lymphomaPeter Martin, Amy Chadburn, Paul Christos, et al.
Pageof 77